Fenny Hui Fen Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fenny Hui Fen Tang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Renata Pasqualini
Rutgers Cancer Institute , Newark, NJ 07101
2 shared publications - Wadih Arap
Rutgers Cancer Institute , Newark, NJ 07101
2 shared publications - Andre Azevedo Reis Teixeira
Institute for Protein Innovation , Boston, MA 02115
1 shared publication Andréia Kuramoto
Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, SP, 05403-000, Brazil
1 shared publicationCarlos Hernique Gomes
Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, 05508-000, Brazil
1 shared publicationChristopher Markosian
Rutgers Cancer Institute , Newark, NJ 07101
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (11)
PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression
PPP2R1A, the predominant scaffolding subunit of the larger serine/threonine protein phosphatase 2A (PP2A), has been implicated in several solid tumors. Recently, somatic inactivating mutations in PPP2R1A have been shown to be associated with increased intratumoral inflammation and improved survival in patients undergoing dual immune checkpoint blockade for platinum-resistant ovarian clear-cell carcinoma. However, the structural and functional basis for this biological phenomenon has not yet been elucidated. We have previously reported PPP2R1A-mediated heterotypic–homodimeric protein–protein interactions between melanoma cells and lymphatic endothelial cells. Here, we demonstrate that PPP2R1A is also present on the surface of ovarian cancer cells. Moreover, we propose that the disruption of such tumor–lymphatic homodimeric interactions and thereby their interface may potentially be a causative factor for enhanced immune cell enrichment and inflammatory signaling within the tumor microenvironment, ultimately translating to improved survival with immune checkpoint inhibitors.
- 22 October 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (11)
Open AccessPPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression
PPP2R1A, the predominant scaffolding subunit of the larger serine/threonine protein phosphatase 2A (PP2A), has been implicated in several solid tumors. Recently, somatic inactivating mutations in PPP2R1A have been shown to be associated with increased intratumoral inflammation and improved survival in patients undergoing dual immune checkpoint blockade for platinum-resistant ovarian clear-cell carcinoma. However, the structural and functional basis for this biological phenomenon has not yet been elucidated. We have previously reported PPP2R1A-mediated heterotypic–homodimeric protein–protein interactions between melanoma cells and lymphatic endothelial cells. Here, we demonstrate that PPP2R1A is also present on the surface of ovarian cancer cells. Moreover, we propose that the disruption of such tumor–lymphatic homodimeric interactions and thereby their interface may potentially be a causative factor for enhanced immune cell enrichment and inflammatory signaling within the tumor microenvironment, ultimately translating to improved survival with immune checkpoint inhibitors.